CTOs on the Move

Gilda'S Club

www.gildasclubgr.org

 
Gilda'S Club is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

United Medical Solutions

United Medical Solutions is a Idaho Falls, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Center for Advanced Medical Education

Center for Advanced Medical Education, Inc. is a Lambertville, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

YO1 Center

YO1 Center is a destination well-being place which enhances health, agility and longevity and brings your state of mind to bliss and happiness. Built at the erstwhile Kutsher`s Resort in lush green surroundings that have two large lakes, it gives guests the opportunity to naturally revitalize their mind and body by employing the Eastern practices brought all the way from India, namely Naturopathy (or Nature Cure), Ayurveda, Yoga and Meditation, Physical Therapy, Acupuncture, Diet and Nutrition. YO1 (or Yauvan) in Sanskrit means Youth. It is the golden period in every human being`s life between teenage and adulthood. It highlights the yogic behavior of every individual in all walks of life. YO1 represents the manifestation of Yoga to fulfill the human quest of attaining eternal youth, through a complete rejuvenation of mind, body and soul. YO1 is about You+1, the literal Sanskrit meaning of Yoga being the `divine union`.

Thorek Memorial Hospital

Thorek Memorial Hospital is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Thorek Memorial Hospital is based in Chicago, IL. You can find more information on Thorek Memorial Hospital at www.thorek.org

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.